Identification of a dendritic cell receptor that couples sensing of necrosis to immunity

Nature

Volumn 458, Issue 7240, 2009, Pages 899-903

  Sancho, David ^a   Joffre, Olivier P ^a   Keller, Anna M ^a   Rogers, Neil C ^a   Martínez, Dolores ^a   Hernanz Falcón, Patricia ^a   Rosewell, Ian ^a   Sousa, Caetano Reis E ^a  

^a IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; CELL RECEPTOR; CLEC9A PROTEIN; LECTIN; PROTEIN DERIVATIVE; PROTEIN KINASE SYK; TYROSINE; UNCLASSIFIED DRUG;

ANTIGEN; CELL ORGANELLE; IMMUNE RESPONSE; IMMUNOASSAY; PATHOLOGY; TUMOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CROSS PRESENTATION; DENDRITIC CELL; ENZYME ACTIVATION; IMMUNITY; IMMUNOGENICITY; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NECROSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEPLETION; PROTEIN FUNCTION; REGULATORY MECHANISM;

ANIMALS; ANTIGENS, CD8; CD8-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; CROSS-PRIMING; DENDRITIC CELLS; HUMANS; LECTINS, C-TYPE; LIGANDS; MICE; NECROSIS; PHAGOCYTOSIS; RECEPTORS, IMMUNOLOGIC; RECEPTORS, MITOGEN; SIGNAL TRANSDUCTION;

EID: 67249158956     PISSN: 00280836     EISSN: 14764687     Source Type: Journal    
DOI: 10.1038/nature07750     Document Type: Article

References (26)

1. Rock, K. L. & Kono, H. The inflammatory response to cell death, Annu. Rev. Pathol. 3, 99-126 (2008).
2. Gallucci, S., Lolkema, M. & Matzinger, P. Natural adjuvants: endogenous activators of dendritic cells. Nature Med. 5, 1249-1255 (1999).
3. Shi, Y., Zheng, W. & Rock, K. L. Cell injury releases endogenous adjuvants that stimulate cytotoxic T cell responses, Proc, Natl Acad. Sci. USA 97, 14590-14595 (2000).
4. Sauter, B. et al. Consequences of cell death. Exposure to necrotic tumor cells, but not primary tissue cells or apoptotic cells, induces the maturation of immunostimulatory dendritic cells. J. Exp. Med. 191, 423-434 (2000).
5. Matzinger, P. Tolerance, danger, and the extended family. Annu. Rev. Immunol. 12, 991-1045 (1994).
6. Matzinger, P. The danger model: a renewed sense of self. Science 296, 301-305 (2002).
7. Villadangos, J. A. & Schnorrer, P. Intrinsic and cooperative antigen-presenting functions of dendritic-cell subsets in vivo. Nature Rev. Immunol. 7, 543-555 (2007),
8. Sancho, D. et al. Tumor therapy in mice via antigen targeting to a novel, DC-restricted C-type lectin, J. Clin. Invest 118, 2098-2110 (2008).
9. + dendritic cells and a subset of monocytes, J. Biol. Chem. 283, 16693-16701 (2008),
10. Caminschi, I. et al. The dendritic cell subtype restricted C-type lectin Clec9A isa target for vaccine enhancement, Blood 112, 3264-3273 (2008).
11. Karttunen, J., Sanderson, S. & Shastri, N. Detection of rare antigen-presenting cells by the lacZ T-cell activation assay suggests an expression cloning strategy for T-cell antigens. Proc. Natl Acad. Sci. USA 89, 6020-6024 (1992).
12. Brown, G. D. & Gordon, S. Immune recognition. A new receptor for β-glucans. Nature 413, 36-37 (2001).
13. - dendritic eell equivalents in Fms-like tyrosine kinase 3 ligand bone marrow cultures, J. Immunol. 174, 6592-6597 (2005).
14. Robinson, M. J., Sancho, D., Slack, E. C., LeibundGut-Landmann, S. & Reis e Sousa, C. Myeloid C-type lectins in innate immunity. Nature Immunol. 7, 1258-1265 (2006).
15. LeibundGut-Landmann, S., Osorio, F., Brown, G. D. & Reis e Sousa, C Stimulation of dendritic cells via the dectin-1/Syk pathway allows priming of cytotoxic T-cell responses. Blood 112, 4971-4980 (2008).
16. Casares, N. et al. Caspase-dependent immunogenicity of doxorubicin-induced tumor cell death. J. Exp. Med. 202, 1691-1701 (2005).
17. Obeid, M. et al. Calreticulin exposure dictates the immunogenicity of cancer eel death, Nature Med. 13, 54-61 (2006).
18. Apetoh, L. et al. Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy. Nature Med. 13, 1050-1059 (2007).
19. Mahnke, K. et al. The dendritic eell receptor for endocytosis, DEC-205, can recycle and enhance antigen presentation via major histocompatibility complex class II-positlve lysosomal compartments. J. Cell Biol. 151, 673-684 (2000).
20. Burgdorf, S., Kautz, A., Böhnert, V., Knolle, P. A. & Kurts, C. Distinct pathways of antigen uptake and intracellular routing in CD4and CDS T cell activation, Science 316, 612-616 (2007).
21. LeibundGut-Landmann, S. et al. Syk- and CARD9-dependent coupling of innate immunity to the induction of T helper cells that produce interleukin 17, Nature Immunol. 8, 630-638 (2007).
22. Janssen, E. et al. Efficient T cell activation via a Toll-interleukin 1 receptor-independent pathway. Immunity 24, 787-799 (2006).
23. Kim, H. S. et al. Toll-like receptor 2 senses β-cell death and contributes to the initiation of autoimmune diabetes. Immunity 27, 321-333 (2007).
24. Cavassani, K. A. et al. TLR3 is an endogenous sensor of tissue necrosis during acute inflammatory events. J. Exp. Med. 205, 2609-2621 (2008).
25. Ziegenfuss, J. S. et al. Draper-dependent glial phagocytic activity is mediated by Src and Syk family kinase signalling, Nature 453, 935-939 (2008).
26. Yamasaki, S. et al. Mincle is an ITAM-coupled activating receptor that senses damaged cells. Nature Immunol. 9, 1179-1188 (2008).